Warfarin skin necrosis associated with protein S deficiency and a mutation in the methylenetetrahydrofolate reductase gene

Clin Exp Dermatol. 2004 Jan;29(1):35-6. doi: 10.1111/j.1365-2230.2004.01443.x.

Abstract

The use of warfarin is rarely complicated by skin necrosis. We describe a 50-year-old woman who presented with a left leg deep venous thrombosis and subsequent pulmonary embolism. She was initially anticoagulated with low-molecular weight heparin and subsequently warfarin. Within 4 days abdominal skin necrosis developed. Investigations revealed the presence of protein S deficiency and in addition, a mutation in the methylenetetrahydrofolate reductase gene (MTHFR). We present, to our best knowledge, the first case of warfarin skin necrosis associated with a methylenetetrahydrofolate reductase mutation.

Publication types

  • Case Reports

MeSH terms

  • Anticoagulants / adverse effects*
  • Drug Eruptions / etiology*
  • Female
  • Humans
  • Leg / blood supply
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics*
  • Middle Aged
  • Mutation / genetics*
  • Necrosis
  • Protein S Deficiency / complications*
  • Venous Thrombosis / drug therapy
  • Warfarin / adverse effects*

Substances

  • Anticoagulants
  • Warfarin
  • Methylenetetrahydrofolate Reductase (NADPH2)